0001640455-22-000017.txt : 20220203
0001640455-22-000017.hdr.sgml : 20220203
20220203193722
ACCESSION NUMBER: 0001640455-22-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURRAY RICHARD /CA/
CENTRAL INDEX KEY: 0001242935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 22590396
MAIL ADDRESS:
STREET 1: 22643 WOODRIDGE CT
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_164393502683270.xml
FORM 4
X0306
4
2022-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001242935
MURRAY RICHARD /CA/
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
1
0
0
CEO and President
Common Stock
2022-02-01
4
A
0
87500
0
A
273077
D
Stock Option (Right to Buy)
7.56
2022-02-01
4
A
0
175000
0
A
2032-02-01
Common Stock
175000.0
175000
D
The option will vest quarterly in 16 equal installments following January 1, 2022.
/s/ Kim C. Drapkin, Attorney-in-Fact
2022-02-03